NEW YORK (GenomeWeb) – Shares of Foundation Medicine and Enzo Biochem each rose around 30 percent month over month in March, leading the GenomeWeb Index to a gain of around 2 percent.

The GW Index, which includes 26 firms in the omics tools and molecular diagnostics industries, outperformed the Dow Jones Industrial Average, which was down nearly 1 percent; the Nasdaq Composite, which was up a little more than 1 percent; and the Nasdaq Biotech Index, which finished March down 1 percent. Overall, 18 of the 26 stocks tracked in the GW Index made positive gains in the month.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Microsoft co-founder Paul Allen also contributed to brain research, NPR reports.

The New York Times reports on the shifting interpretations of what some genetic variants mean over time.

In Cell this week: investigation of metastatic tumor evolution, more than 16,000 genetic variants introduced into the budding yeast model organism, and more.

MIT's Technology Review reports on Genentech's pursuit of personalized cancer vaccines.